Series B - N-Power Medicine

Series B - N-Power Medicine

Investment Firm

Overview

N-Power Medicine specializes in drug development and clinical research.

Announced Date

May 21, 2024

Closed on Date

Jul 01, 2024

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund is a early_stage_venture and private_equity firm.

Participant Investors

1

Investor Name
Participant InvestorMerck Global Health Innovation Fund

Round Details and Background

N-Power Medicine raised an undisclosed amount on 2024-05-21 in Series B

N-Power Medicine specializes in drug development and clinical research.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 21, 2024
Series B - N-Power Medicine
1-undefined

Recent Activity

There is no recent news or activity for this profile.